FMC Corporation (FMC) Business & Investor Dossier

FMC Corporation makes money by selling crop protection chemicals -- insecticides, herbicides, and fungicides -- to farmers, distributors, and agrochemical retailers globally. Farmers use these products to protect their crops from insects, weeds, and diseases that would otherwise reduce yields. FMC earns revenue from the sale of active ingredients it has patented and developed, as well as formulated products (the active ingredient combined with solvents, surfactants, and other components that make it effective and safe to apply). FMC's pricing power comes from patented active ingredients, especially its diamide insecticides (Rynaxypyr and Cyazypyr) which are highly effective against a broad range of insects and have become global market leaders. After selling its specialty chemicals and lithium businesses to focus exclusively on crop protection, FMC is a pure-play agricultural chemicals company.

Diamides are a class of insecticide discovered and patented by FMC's research team. FMC's two primary diamide active ingredients -- Rynaxypyr (chlorantraniliprole) and Cyazypyr (cyantraniliprole) -- became global best-sellers after their introduction in the late 2000s and 2010s. Diamides work by activating ryanodine receptors in insects, causing uncontrolled muscle contractions and insect paralysis, but have low toxicity to mammals, birds, and bees at normal application rates. They are highly effective against lepidopteran pests (caterpillars, moths, borers) that are major problems for rice, corn, soybeans, and fruits and vegetables. FMC licensed diamide technology to Syngenta, which sells chlorantraniliprole under the brand Coragen -- a significant source of licensing revenue for FMC beyond its own product sales. The diamide patents have begun expiring, allowing generic manufacturers to produce these active ingredients, which is a major headwind for FMC's long-term revenue and pricing power.

FMC Corporation was historically a diversified chemicals and industrial company with businesses including agricultural chemicals, specialty chemicals, industrial minerals, and machinery. The transformation to a pure-play agricultural chemicals company happened through a series of divestitures over approximately 15 years. FMC sold its industrial machinery businesses, spun off its lithium business as Livent (2018), divested its specialty chemicals business to Tronox (2010 and subsequent), and acquired DuPont's crop protection businesses in 2017 as part of the DuPont-Dow merger's required divestitures -- a deal that significantly expanded FMC's portfolio of active ingredients and global reach. By 2019, FMC was a focused pure-play crop protection company. The transformation was intended to allow investors to value FMC's agricultural chemicals business on its own merits rather than as part of a diversified conglomerate, and to allow management to focus entirely on crop protection research and commercialization.

FMC was significantly impacted by a severe destocking crisis in the agricultural chemicals industry in 2022-2023. The crisis originated during COVID-19 supply chain disruptions when distributors and farmers over-ordered chemicals to ensure supply. When demand normalized and supply chains recovered, the channel (distributors, cooperatives, retailers) had excessive inventory and stopped ordering new product. This caused FMC's revenue and earnings to fall sharply in 2023 even though end-market demand from farmers remained relatively stable. The destocking was compounded by a weak Brazilian agricultural market (a major crop protection market), currency headwinds in Brazil and other emerging markets, and pricing pressure from Chinese generic manufacturers who ramped up production of diamide active ingredients as some patents expired. FMC's 2023 results were significantly below 2022 levels and the company cut its dividend to conserve cash. Recovery from the destocking began in 2024 as channel inventories normalized.

FMC's main risks include: patent expiration on its most important diamide active ingredients (Rynaxypyr patents have begun expiring, enabling generic competition), which is the single most significant long-term threat to FMC's revenue and margin structure; generic competition from Chinese agrochemical manufacturers that produce active ingredients at lower cost once patents expire; agricultural market cyclicality, as crop prices, weather events, and farmer income affect pesticide spending; channel inventory cycles (the 2022-2023 destocking crisis showed how excess distribution inventory can sharply reduce orders for 1-2 years even when end demand is stable); regulatory risk from registration of crop protection products (approvals can be revoked, use restrictions imposed, or re-registration required by EPA and international authorities); currency risk from global revenue in emerging market currencies; and the challenge of replacing diamide revenue as those products mature -- new active ingredient discovery is expensive, long-duration, and uncertain.